Expression of VEGFxxxb, the inhibitory isoforms of VEGF, in malignant melanoma (original) (raw)

Biology of Melanoma Metastasis

Melanoma, 2017

View PDFchevron_right

Genes and signaling pathways affecting the pathogenesis of melanoma

Bridget Varughese

Postdoc Journal, 2013

View PDFchevron_right

Immunologic escape and angiogenesis in human malignant melanoma

Journal of the American Academy of Dermatology, 2003

View PDFchevron_right

Identification of new genes associated with melanoma

Experimental Dermatology, 2011

View PDFchevron_right

Altered molecular pathways in melanocytic lesions

Maria Scatolini

International Journal of Cancer, 2009

View PDFchevron_right

‘Loss of pigment epithelium-derived factor enables migration, invasion and metastatic spread of human melanoma’

Daniela Mihic-probst

Oncogene, 2009

View PDFchevron_right

Prognostic value of serum VEGF in melanoma patients: a pilot study

Giuseppe Castello

Anticancer research

View PDFchevron_right

Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model

Fred C. G. J. Sweep

Microvascular Research, 2009

View PDFchevron_right

Evaluation of VEGF expression correlates with COX-2 expression in pleomorphic adenoma, mucoepidermoid carcinoma and adenoid cystic carcinoma

Dental research journal, 2020

View PDFchevron_right

Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays

Human pathology, 2010

View PDFchevron_right

Meeting report: consensus from the first and second Global Workshops in Melanoma November 19-20, 2008

Wolfram Samlowski, Sancy Leachman

Pigment Cell & Melanoma Research, 2009

View PDFchevron_right

VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2

Aristotelis Bamias

International Journal of Cancer, 2011

View PDFchevron_right

Tumorigenicity of Vero cells

John Petricciani

Journal of Biological Standardization, 1984

View PDFchevron_right

Phase I/II and Pharmacodynamic Study of Dovitinib (TKI258), an Inhibitor of Fibroblast Growth Factor Receptors and VEGF Receptors, in Patients with Advanced Melanoma

Humphrey Gardner

Clinical Cancer Research, 2011

View PDFchevron_right

Functional results one-year following the anti-VEGF therapy in macular pathology

Balneo and PRM Research Journal, 2023

View PDFchevron_right

Medicine 247 VEGF IN SКIN MELANOMA-ROLE AND GENETIC POLYMORPHYSMS

Tatyana Vlaykova

2012

View PDFchevron_right

Rheumatoid factor positive plasma and humoral cytotoxicity to malignant melanoma

Cancer, 1978

View PDFchevron_right

The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis

Christopher Morris

BMC Medical Genomics, 2008

View PDFchevron_right

Expression of COX-2 and Prognostic Outcome in Uveal Melanoma

Current Eye Research, 2008

View PDFchevron_right

Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis

Mayo Clinic Proceedings, 2007

View PDFchevron_right

Increased expression of stem cell markers in malignant melanoma

Modern Pathology, 2006

View PDFchevron_right

Differential sensitivity of breast cancer and melanoma cells to proteasome inhibitor Velcade

International Journal of Molecular Medicine, 1998

View PDFchevron_right

Co-expression of vascular endothelial growth factor C (VEGF-C) and c-erbB2 in human breast carcinoma

European Journal of Cancer, 2003

View PDFchevron_right

Regulation of VEGF-A in Uveal Melanoma

Investigative Ophthalmology & Visual Science, 2010

View PDFchevron_right

Bringing Down Cancer Aircraft: Searching for Essential Hypomutated Proteins in Skin Melanoma

PLOS ONE, 2015

View PDFchevron_right